• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Prognostic value of multiple repeated biomarkers in pulmonary arterial hypertension associated with congenital heart disease.

作者信息

van Dissel Alexandra C, Blok Ilja M, Zwinderman Aeilko H, van Dijk Arie P J, Duijnhouwer Anthonie L, de Winter Robbert J, Mulder Barbara J M, Bouma Berto J

机构信息

Department of Clinical and Experimental Cardiology, Amsterdam Cardiovascular Sciences, Amsterdam UMC, University of Amsterdam, Heart Centre, Amsterdam, The Netherlands.

Netherlands Heart Institute, Utrecht, The Netherlands.

出版信息

Eur J Heart Fail. 2019 Feb;21(2):249-251. doi: 10.1002/ejhf.1363. Epub 2018 Dec 6.

DOI:10.1002/ejhf.1363
PMID:30520544
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6607513/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a948/6607513/c50a2557e805/EJHF-21-249-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a948/6607513/c50a2557e805/EJHF-21-249-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a948/6607513/c50a2557e805/EJHF-21-249-g001.jpg

相似文献

1
Prognostic value of multiple repeated biomarkers in pulmonary arterial hypertension associated with congenital heart disease.多种重复生物标志物在先天性心脏病相关肺动脉高压中的预后价值
Eur J Heart Fail. 2019 Feb;21(2):249-251. doi: 10.1002/ejhf.1363. Epub 2018 Dec 6.
2
[Expression and role of urotensin II on the lung of patients with pulmonary hypertension with congenital heart disease].[尾加压素II在先天性心脏病合并肺动脉高压患者肺组织中的表达及作用]
Zhonghua Er Ke Za Zhi. 2012 Sep;50(9):689-91.
3
Pulmonary Hypertension in Congenital Heart Disease: Beyond Eisenmenger Syndrome.先天性心脏病中的肺动脉高压：超越艾森曼格综合征
Cardiol Clin. 2015 Nov;33(4):599-609, ix. doi: 10.1016/j.ccl.2015.07.003. Epub 2015 Aug 13.
4
[Changes in oxygenation indexes with the use of nitric oxide in the postoperative period of congenital heart disease surgery in patients with severe pulmonary hypertension].[重度肺动脉高压患者先天性心脏病手术后使用一氧化氮期间氧合指数的变化]
Arch Cardiol Mex. 2001 Apr-Jun;71(2):121-6.
5
[Pulmonary arterial hypertension in congenital cardiopathies].[先天性心脏病中的肺动脉高压]
Ann Med Interne (Paris). 1981;132(5):297-9.
6
Pulmonary hypertension associated with congenital cardiac disease.与先天性心脏病相关的肺动脉高压
Cardiol Young. 2009 Aug;19(4):311-4. doi: 10.1017/S1047951109990138. Epub 2009 May 29.
7
Management of patients with pulmonary arterial hypertension due to congenital heart disease: recent advances and future directions.先天性心脏病所致肺动脉高压患者的管理：最新进展与未来方向
Expert Rev Cardiovasc Ther. 2015 Dec;13(12):1377-92. doi: 10.1586/14779072.2015.1101341. Epub 2015 Oct 16.
8
Prognostic Value of Pulmonary Artery Compliance in Patients with Pulmonary Arterial Hypertension Associated with Adult Congenital Heart Disease.肺动脉顺应性对成人先天性心脏病相关肺动脉高压患者的预后价值
Int Heart J. 2017 Oct 21;58(5):731-738. doi: 10.1536/ihj.16-449. Epub 2017 Sep 30.
9
Predicting prognosis of children with pulmonary arterial hypertension: the importance of multimodal expert assessment.预测儿童肺动脉高压的预后：多模式专家评估的重要性。
Heart. 2014 Sep;100(17):1305-7. doi: 10.1136/heartjnl-2014-306010.
10
Pulmonary vascular disease in adults with congenital heart disease.成人先天性心脏病中的肺血管疾病
Circulation. 2007 Feb 27;115(8):1039-50. doi: 10.1161/CIRCULATIONAHA.105.592386.

引用本文的文献

1
Predicting Outcome in Adult Patients With Congenital Heart Disease: A Systematic Review and Meta-Analysis on the Predictive Value of NT-proBNP and High-Sensitive Troponin T.预测成年先天性心脏病患者的预后：关于NT-proBNP和高敏肌钙蛋白T预测价值的系统评价和荟萃分析
Int J Vasc Med. 2025 Jul 3;2025:1210312. doi: 10.1155/ijvm/1210312. eCollection 2025.

本文引用的文献

1
Past and current cause-specific mortality in Eisenmenger syndrome.艾森曼格综合征的过去和现在的病因特异性死亡率。
Eur Heart J. 2017 Jul 7;38(26):2060-2067. doi: 10.1093/eurheartj/ehx201.
2
A multimarker multi-time point-based risk stratification strategy in acute heart failure: results from the RELAX-AHF trial.基于多标志物多时间点的急性心力衰竭风险分层策略：RELAX-AHF 试验结果。
Eur J Heart Fail. 2017 Aug;19(8):1001-1010. doi: 10.1002/ejhf.749. Epub 2017 Jan 30.
3
Predictors of Death in Contemporary Adult Patients With Eisenmenger Syndrome: A Multicenter Study.
当代成人艾森曼格综合征患者死亡的预测因素：一项多中心研究。
Circulation. 2017 Apr 11;135(15):1432-1440. doi: 10.1161/CIRCULATIONAHA.116.023033. Epub 2016 Dec 15.
4
2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT).2015年欧洲心脏病学会（ESC）/欧洲呼吸学会（ERS）肺动脉高压诊断和治疗指南：欧洲心脏病学会（ESC）和欧洲呼吸学会（ERS）肺动脉高压诊断和治疗联合工作组：得到以下组织认可：欧洲儿科和先天性心脏病协会（AEPC）、国际心肺移植学会（ISHLT）。
Eur Heart J. 2016 Jan 1;37(1):67-119. doi: 10.1093/eurheartj/ehv317. Epub 2015 Aug 29.
5
Blood biomarkers and their potential role in pulmonary arterial hypertension associated with congenital heart disease. a systematic review.血液生物标志物及其在先天性心脏病相关肺动脉高压中的潜在作用。一项系统综述。
Int J Cardiol. 2014 Jul 1;174(3):618-23. doi: 10.1016/j.ijcard.2014.04.156. Epub 2014 Apr 22.
6
Usefulness of serum brain natriuretic peptide to predict adverse events in patients with the Eisenmenger syndrome.血清脑利钠肽在预测艾森曼格综合征患者不良事件中的作用。
Am J Cardiol. 2012 Nov 15;110(10):1523-6. doi: 10.1016/j.amjcard.2012.06.061. Epub 2012 Aug 3.
7
B-type natriuretic peptide concentrations in contemporary Eisenmenger syndrome patients: predictive value and response to disease targeting therapy.当代艾森曼格综合征患者 B 型利钠肽浓度：预测价值及对疾病靶向治疗的反应。
Heart. 2012 May;98(9):736-42. doi: 10.1136/heartjnl-2011-301522. Epub 2012 Mar 7.
8
Prolonged beneficial effect of bosentan treatment and 4-year survival rates in adult patients with pulmonary arterial hypertension associated with congenital heart disease.波生坦治疗对先天性心脏病相关肺动脉高压成年患者的长期有益作用和 4 年生存率。
Int J Cardiol. 2013 Mar 20;164(1):64-9. doi: 10.1016/j.ijcard.2011.06.064. Epub 2011 Jul 1.